Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Sep 19, 2017, 08:15 ET Global Coalition Against Cervical Cancer Supports Draft USPSTF Recommendations, Is Encouraged by Focus on Self-Collection for HPV Testing

The Global Coalition Against Cervical Cancer (GC3) applauds the recent release of draft cervical cancer screening recommendations by the United...


Sep 19, 2017, 08:05 ET Cardax Welcomes Cardiovascular Research Breakthrough

Cardax, Inc. (OTCQB:CDXI) welcomes the findings of a clinical study recently published in the New England Journal of Medicine that validate the...


Sep 19, 2017, 08:02 ET 4G Clinical Named Finalist for 2017 Scrip Award

4G Clinical announced its recognition today as a finalist in the 2017 Scrip Awards for its RTSM solution, Prancer. Shortlisted in the 'Best...


Sep 19, 2017, 08:00 ET BERG Broadens Relationship With The Department Of Defense (DoD) Center For Prostate Disease Research With New Predictive Biomarker Test For Prostate Cancer

BERG, a biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the completion of clinical...


Sep 19, 2017, 07:30 ET ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease

Clinical trials evaluating PMN310 expected to initiate in 2019 TSX: PMN TORONTO and CAMBRIDGE, MA, Sept. 19, 2017 /PRNewswire/ - ProMIS...


Sep 19, 2017, 07:30 ET Estudo demonstra potencial de fremanezumabe para atender as necessidades de pacientes com enxaqueca crônica e episódica

A Teva Farmacêutica Ltda. apresentou dados que avaliam o fremanezumabe, um tratamento em investigação para a profilaxia de enxaqueca no 18º...


Sep 19, 2017, 07:03 ET Sepsis Power Hour Solution Accelerates Care, Reduces Costly Treatment Measures

Sepsis is the primary cause of death from infection worldwide, with over 18 million cases per year, and represents the most costly condition...


Sep 19, 2017, 07:03 ET La solución Sepsis Power Hour acelera la asistencia y reduce las medidas de tratamiento costosas

La sepsis es la causa principal de muerte por infección en todo el mundo, con más de 18 millones de casos al año y representa el problema más...


Sep 19, 2017, 07:00 ET Anti-Chemoresistance Study on DolCas BCM-95 Shows Excellent Results

A new clinical study investigated the mechanism of BCM-95®, a high-potency turmeric extract in treating pancreatic cancer. The study revealed...


Sep 19, 2017, 06:30 ET Prometic Reports Positive Clinical Data from Ongoing PBI-4050 Study in Alström Syndrome Patients

- Sustained safety observed over 48 weeks of treatment - Beneficial clinical effects in liver sustained over 48 weeks of treatment...


Sep 19, 2017, 06:30 ET BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin™

BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic...


Sep 19, 2017, 05:24 ET Indivumed and Helomics Partner to Unlock the Power of Cancer Biospecimens for Drug Discovery and Development

Indivumed GmbH (Indivumed) and Helomics® Corporation (Helomics) announce their intentions to collaborate to analyze human cancer biospecimens and...


Sep 19, 2017, 04:38 ET Rapid Medical: Erster Patient in TIGERTRIEVER-Register für akute ischämische Schlaganfälle aufgenommen

- Dieses Post-Market-Register soll die Sicherheit und Leistung des TIGERTRIEVER-Revaskularisierungsgerät in der Praxis bewerten. Rapid Medical,...


Sep 19, 2017, 04:33 ET Rapid Medical : le premier patient inscrit dans le registre du TIGERTRIEVER pour le traitement de l'AVC ischémique aigu

- Le registre post-commercialisation évaluera l'innocuité et les performances dans la vie réelle du dispositif de revascularisation...


Sep 19, 2017, 03:01 ET Daten zur Kombination von Lenvatinib und Pembrolizumab zeigen beachtliche Ansprechraten für Patienten mit metastasiertem Nierenzellkarzinom

- Aktualisierte Ergebnisse der Kohorte mit metastasiertem Nierenzellkarzinom aus Studie 111 unterstützen die weitere Untersuchung der...


Sep 19, 2017, 03:01 ET Datos de la combinación de lenvatinib y pembrolizumab demuestran tasas de respuesta destacadas…

Datos de la combinación de lenvatinib y pembrolizumab demuestran tasas de respuesta destacadas en pacientes con carcinoma de células renales...


Sep 18, 2017, 20:30 ET Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved...


Sep 18, 2017, 16:25 ET Los datos pragmáticos confirman la efectividad a largo plazo de la termoplastia bronquial

Pacientes con asma grave muestran una mejoría clínica sostenida Boston Scientific (NYSE: BSX) ha anunciado hoy los resultados de un...


Sep 18, 2017, 16:20 ET Daten aus der Praxis bestätigen die Langzeitwirkung von bronchialer Thermoplastie

Patienten mit schwerem Asthma weisen nachhaltige klinische Verbesserung auf Boston Scientific (NYSE: BSX) gab heute die Ergebnisse einer...


Sep 18, 2017, 14:39 ET Institut Marquès stellt seine Studien zu Musik und dem Beginn des Lebens am Massachusetts Institute of Technology vor

- Dr. Marisa López-Teijón, Leiterin des international anerkannten Zentrums für Künstliche Befruchtung, erhielt den Ig-Nobelpreis für Medizin - Die...


Most Viewed